Kathy Rock

University of Toronto

Papers

1

Total Citations

5

H-Index

1

About

Dr. Kathy Rock is a leading clinical investigator in head and neck oncology, with a focused expertise in the management of p16-positive, HPV-related oropharyngeal cancers. Her seminal 2018 work, "Surgery- vs Radiation-Based Therapy for p16+/HPV-Related Oropharyngeal Cancers," has garnered 5 citations and stands as a pivotal comparative analysis in the field. In this study, Dr. Rock systematically evaluated the efficacy and toxicity profiles of surgical versus radiation-based treatment modalities, providing critical evidence that helps guide de-escalation strategies for this distinct patient population. Her contributions are particularly significant in the ongoing effort to reduce long-term treatment morbidity without compromising oncologic outcomes. By clarifying the relative benefits and risks of these two primary approaches, Dr. Rock has directly influenced clinical decision-making and trial design. Her research is highly regarded among head and neck surgeons and radiation oncologists, and she is recognized for her commitment to refining personalized treatment paradigms. Dr. Rock’s work continues to shape the standard of care for patients with HPV-driven oropharyngeal cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Surgery- vs Radiation-Based Therapy for p16+/HPV-Related Oropharyngeal Cancers
5 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: University of Toronto

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago